Technology | 2019.09.06
SoniVie Receives FDA Breakthrough Device Designation for the TIVUS System in the Treatment of Pulmonary Arterial Hypertension (PAH)
- Designation facilitates more rapid approval and reimbursement for a breakthrough technology that offers significant advantages over current PAH treatment options -
(PRWeb September 06, 2019)
Read the full story at https://www.prweb.com/releases/sonivie_receives_fda_breakthrough_device_designation_for_the_tivus_system_in_the_treatment_of_pulmonary_arterial_hypertension_pah/prweb16553954.htm
For more information, please visit
https://www.prweb.com/releases/sonivie_r[...]rtension_pah/prweb16553954.htm
Follow us on
Instagram is adding automatic in-app text translation - The Verge views: 1574
Instagram is adding automatic in-app text translation - The Verge views: 1508